← Open Payments lookup

STACIA GOLLIHAR: Open Payments

NPI 1265741508 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,012 in 47 payments from 29 companies in 2025. Trend: 2023 $133 · 2024 $847 · 2025 $1,012

Food & beverage: $1,012
CompanyPaymentsAmount
Exelixis Inc.4$93
Novartis Pharmaceuticals Corporation4$91
Gilead Sciences, Inc.3$86
Janssen Biotech, Inc.2$60
ABBVIE INC.2$51
Kite Pharma, Inc.2$50
Eisai Inc.2$42
BeiGene USA, Inc.2$40
TerSera Therapeutics LLC2$40
Celgene Corporation2$38

Products named: CABOMETYX, Trodelvy, TEVIMBRA, PLUVICTO, Yescarta, Lenvima, Zoladex, REBLOZYL.

Industry payments across TX — which companies pay providers there.